For the three years preceding the Bridge launch, a parallel market for GLP-1 medications had been providing actual price competition for Novo Nordisk and Eli Lilly via compounding pharmacies operating under FDAs 503A and 503B framework
Developed initially to manage type 2 diabetes, these medications are now being prescribed (and in some cases self-sourced) to help people lose significant amounts of weight, and quickly
Colhoun, MD, the AXA Chair in Medical Informatics and Life Course Epidemiology at the University of Edinburgh in Scotland, United Kingdom, and lead author of this study, in a press release
Do you offer medical weight loss in Gloucester County, NJ
Using a CGM with Signos: Real-Time Data, Backed by AI Signos pairs a real-time glucose biosensor with AI trained on tens of millions of data points to deliver personalized, science-backed guidance for weight management and health
Microdosing approaches have gained popularity